through a layer of Al O (5 cm), dried over MgSO , and evaporated to afford a 1:1 mixture of lactol (5a) and hydroxyaldehyde
2
3
4
1
3
(
5b) (1.93 g, 98%). The PMR and C NMR parameters of 5a and 5b were identical to those reported previously [4].
Diisobutyl-(7S-isopropyl-4R-methyloxepan-2S-oyl)aluminum (2). Asolution of 1 (1.00 g, 5.9 mmol) in anhydrous
CH Cl (24 mL) at ꢀ70°C was treated dropwise with a solution (73%) of DIBAH (1.5 mL, 6.0 mmol) in toluene and stirred for
2
2
1
3
1
1
5 min. A sample was placed into an ampul. The NMR spectra were recorded. C NMR spectrum (C D , ꢅ, ppm): 18.76 and
9.44 [both q, (CH ) CH], 23.66 (q, 4-CH ), 30.46 (t, C-5), 30.95 (d, C-4), 33.49 [d, (H C) CH], 35.87 (t, C-6), 45.71 (t,
6 6
3
2
3
3
2
C-3), 82.35 (d, C-7), 97.78 (d, C-2), i-BuO: 23.20 (t, CH ), 25.98 (d, CH), 28.55 (q, 2CH ).
2
3
General Method for Wittig Olefination. a. A suspension of phosphonium salt (6.5 mmol) in anhydrous THF
15 mL) at ꢀ70°C was treated with a solution of n-BuLi (5.6 mL, 1.17 M, 6.5 mmol) in hexane, held for 1 h at room temperature,
(
cooled to ꢀ70°C, treated sequentially with a solution of 1 (1.00 g, 5.9 mmol) in anhydrous THF (6 mL) and a solution (73%)
of DIBAH (3.0 mL, 12.0 mmol) in toluene, held at ꢀ70°C for 1 h and at 20°C for 16 h, treated with cold H O (12 mL), and
2
filtered through a Schott filter. The solid was rinsed with t-BuOMe (50 mL). The filtrate was dried over Na SO and evaporated.
2
4
The residue was diluted with t-BuOMe (50 mL), filtered through a layer of Al O (5 cm), and evaporated to afford a mixture
2
3
of unsaturated alcohols 4a–d and diol 3.
b. A suspension of phosphonium salt (6.5 mmol) in anhydrous THF (15 mL) at ꢀ70°C was treated with a solution of
n-BuLi (5.6 mL, 1.17 M, 6.5 mmol) in hexane, held for 1 h at room temperature, cooled to ꢀ70°C, treated with a solution of
menthone lactol (5, 1.00 g, 5.8 mmol) in anhydrous THF (6 mL), held at ꢀ70°C for 1 h and at 20°C for 16 h, treated with H O
2
(
2 mL), diluted with t-BuOMe (50 mL), dried over Na SO , and evaporated. The residue was diluted with t-BuOMe (50 mL),
2 4
filtered through a layer of Al O (5 cm), and evaporated to afford unsaturated alcohols 4a–f.
2
3
2
,6R-Dimethyldec-8-en-3S-ol (4a). Prepared by method a (0.58 g, 53%) and method b (0.65 g, 61%), R 0.74
f
(
PE:MTBE, 2:1). PMR spectrum (CDCl , ꢅ, ppm): 0.77–0.88 (9H, m, H-1, 2-CH , 6-CH ), 0.9–1.7 (8H, m, H-2, H-4ꢀH-6,
3 3 3
1
3
H-10), 1.98–2.05 (2H, m, H-7), 3.35–3.55 (1H, m, H-3), 5.18 (1H, s, OH), 5.43–5.79 (2H, m, H-8, H-9). C NMR spectrum
CDCl , ꢅ, ppm): 16.90, 18.92, and 19.59 (all q, C-1, 2-CH , 6-CH ), 12.85 (q, C-10), 31.78 (t, C-4), 32.87 (t, C-5), 33.29 (d,
(
3
3
3
C-6), 33.56 (d, C-2), 39.84 (t, C-7), 67.65 (d, C-3), 124.52 [125.9] (d, C-9), 129.19 [129.82] (d, C-8).
2
,6R-Dimethylundec-8-en-3S-ol (4b). Prepared by method a (0.60 g, 51%) and method b (0.71 g, 62%), R 0.75
f
(
PE:MTBE, 2:1). PMR spectrum (CDCl , ꢅ, ppm): 0.75–0.85 (12H, m, H-1, 2-CH , 6-CH , H-11), 0.9–1.7 (6H, m, H-2,
3 3 3
1
3
H-4ꢀH-6), 1.98–2.05 (4H, m, H-7, H-10), 3.35–3.55 (1H, m, H-3), 5.18 (1H, s, OH), 5.40–5.75 (2H, m, H-8, H-9). C NMR
spectrum (CDCl , ꢅ, ppm): 18.21, 18.84, and 19.65 (all q, C-1, 2-CH , 6-CH ), 16.86 (q, C-11), 27.73 [33.76] (t, C-10), 31.34
3
3
3
(
(
t, C-4), 33.20 (d, C-6), 33.38 (t, C-5), 33.67 (d, C-2), 43.14 (t, C-7), 76.84 (d, C-3), 128.46 [128.30] (d, C-8), 134.05 [134.19]
d, C-9).
2
,6R-Dimethyldodec-8-en-3S-ol (4c). Prepared by method a (0.65 g, 52%) and method b (0.92 g, 75%), R 0.75
f
(
PE:MTBE, 2:1). PMR spectrum (CDCl , ꢅ, ppm): 0.75–0.85 (12H, m, H-1, 2-CH , 6-CH , H-12), 0.9–1.7 (8H, m, H-2,
3 3 3
H-4ꢀH-6, H-11), 1.98–2.05 (4H, m, H-7, H-10), 3.35–3.55 (1H, m, H-3), 5.18 (1H, s, OH), 5.48 (2H, m, H-9, H-10).
1
3
C NMR spectrum (CDCl , ꢅ, ppm): 17.02 (q, C-14), 18.30, 18.80, and 19.60 (all q, C-1, 2-CH , 6-CH ), 31.30 (t, C-4),
3
3
3
2
(
6.20 (t, C-11), 33.16 (d, C-6), 33.40 (t, C-10), 33.00 (t, C-5), 33.43 (d, C-2), 40.20 (t, C-7), 68.30 (d, C-3), 128.30 [128.15]
d, C-8), 132.00 [132.25] (d, C-9).
,6R-Dimethyltridec-8-en-3S-ol (4d). Prepared by method a (0.78 g, 58%) and method b (0.97 g, 74%), R 0.75
2
f
(
PE:MTBE, 2:1). PMR spectrum (CDCl , ꢅ, ppm): 0.75–0.90 (12H, m, H-1, 2-CH , 6-CH , H-13), 0.9–1.7 (10H, m, H-2,
3
3
3
H-4ꢀH-6, H-11, H-12), 1.98–2.50 (4H, m, H-7, H-10), 3.35–3.55 (1H, m, H-3), 5.18 (1H, s, OH), 5.49 (2H, m, H-9, H-10).
1
3
C NMR spectrum (CDCl , ꢅ, ppm): 16.90 (q, C-13), 18.20, 18.70, and 19.50 (all q, C-1, 2-CH , 6-CH ), 31.10 (t, C-12),
3
3
3
3
1
1.40 (t, C-4), 31.5 (t, C-11), 33.10 (d, C-6), 33.27 (t, C-10), 36.15 (t, C-5), 33.27 (d, C-2), 43.00 (t, C-7), 69.88 (d, C-3),
28.29 [128.19] (d, C-8), 131.95 [132.05] (d, C-9).
,6R-Dimethyltetradec-8-en-3S-ol (4e). Prepared by method b (1.23 g, 74%), R 0.77 (PE:MTBE, 2:1).
2
f
1
3
PMR spectral parameters were identical to those published earlier [1]. C NMR spectrum (CDCl , ꢅ, ppm): 15.09 (q, C-14),
3
1
8.36, 18.85, and 19.62 (all q, C-1, 2-CH , 6-CH ), 23.00 (t, C-13), 28.90 (t, C-11), 29.30 (t, C-10), 30.50 (t, C-12), 31.80 (t,
3 3
C-4), 33.60 (d, C-6), 33.70 (t, C-5), 33.97 (d, C-2), 40.00 (t, C-7), 76.90 (d, C-3), 128.20 [128.00] (d, C-8), 131.20 [131.45] (d,
C-9).
2
,6R-Dimethyltetracos-8-en-3S-ol (4f). Prepared by method b (1.72 g, 78%), R 0.80 (PE:MTBE, 2:1). PMR and
f
1
3
C NMR spectral parameters were identical to those published earlier [2].
2
0
3
R,7-Dimethyl-1,6S-octanediol (3). R 0.10 (PE:EtOAc, 7:3), [ꢆ] ꢀ10.3° (c 2.43, CHCl ). IR and NMR spectral
f D 3
parameters were identical to those published earlier [1].
983